SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Endocrinol Metab (Seoul). 2022;37(1):124-137.

Adrenal Morphology as an Indicator of Long-Term Disease Control in Adults with Classic 21-Hydroxylase Deficiency.

, , , , ,

제1저자 김택민, 김정희 · 교신저자 김상윤

PMID 35144332 PMC8901969 DOI 10.3803/EnM.2021.1278 IF 5.1 내분비대사내과
소속 (4)
  1. Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  2. Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  3. Molecular Recognition Research Center, Korea Institute of Science and Technology, Seoul, Korea.
  4. Institute of Radiation Medicine and Kidney Research Institute, Seoul National University Medical Research Center, Seoul, Korea.

Abstract

BACKGROUND Monitoring adults with classical 21-hydroxylase deficiency (21OHD) is challenging due to variation in clinical and laboratory settings. Moreover, guidelines for adrenal imaging in 21OHD are not yet available. We evaluated the relationship between adrenal morphology and disease control status in classical 21OHD.

METHODS This retrospective, cross-sectional study included 90 adult 21OHD patients and 270 age- and sex-matched healthy controls. We assessed adrenal volume, width, and tumor presence using abdominal computed tomography and evaluated correlations of adrenal volume and width with hormonal status. We investigated the diagnostic performance of adrenal volume and width for identifying well-controlled status in 21OHD patients (17α-hydroxyprogesterone [17-OHP] <10 ng/mL).

RESULTS The adrenal morphology of 21OHD patients showed hypertrophy (45.6%), normal size (42.2%), and hypotrophy (12.2%). Adrenal tumors were detected in 12 patients (13.3%). The adrenal volume and width of 21OHD patients were significantly larger than those of controls (18.2±12.2 mL vs. 7.1±2.0 mL, 4.7±1.9 mm vs. 3.3±0.5 mm, P<0.001 for both). The 17-OHP and androstenedione levels were highest in patients with adrenal hypertrophy, followed by those with normal adrenal glands and adrenal hypotrophy (P<0.05 for both). Adrenal volume and width correlated positively with adrenocorticotropic hormone, 17-OHP, 11β-hydroxytestosterone, progesterone sulfate, and dehydroepiandrosterone sulfate in both sexes (r=0.33-0.95, P<0.05 for all). For identifying well-controlled patients, the optimal cut-off values of adrenal volume and width were 10.7 mL and 4 mm, respectively (area under the curve, 0.82-0.88; P<0.001 for both).

CONCLUSION Adrenal volume and width may be reliable quantitative parameters for monitoring patients with classical 21OHD.

Keywords

Adrenal cortexAdrenal hyperplasia, congenitalAdrenal volumeAndrogens

Figures

Fig. 1
Fig. 1 Image analysis of patients with 21-hydroxylase deficiency (21OHD). We evaluated the adrenal morphology according to (A, B) limb width, (C) the presence of an adrenal mass (arrows), and (D) adrenal volume by manual segmentation.
Fig. 2
Fig. 2 Plasma levels of (A) 17α-hydroxyprogesterone (17-OHP) and (B) androstenedione according to the adrenal morphology. Patients with adrenal hypertrophy showed the highest 17-OHP and androstenedione levels, followed by those with normal adrenal glands and adrenal hypotrophy.
Fig. 3
Fig. 3 Correlations between total adrenal volume and hormonal status and adrenal width and hormonal status. Both total adrenal volume and adrenal width correlated positively with (A, B) adrenocorticotropic hormone (ACTH) and (C, D) 17α-hydroxyprogesterone (17-OHP) levels regardless of sex. (E, F) Androstenedione levels correlated positively with adrenal volume in both male and female patients, and with adrenal width in male patients.
Fig. 4
Fig. 4 Receiver operating characteristic curves and box-and-whisker diagrams of adrenal volume and width for classifying well-controlled patients (A, B, C) and patients with at least one metabolic morbidity (D, E, F), respectively. AUC, area under the curve; CI, confidence interval.

그림 출처: PubMed Central 공개 논문 (PMC8901969)

Conflict of interest statement

CONFLICTS OF INTEREST . No potential conflict of interest relevant to this article was reported.

그 밖의 정보
출판 형태
Journal Article
저널
Endocrinology and metabolism (Seoul, Korea) · eISSN 2093-5978
전자 출판
2022-02-08
MeSH
17-alpha-Hydroxyprogesterone · Adrenal Hyperplasia, Congenital* / diagnosis · Adult · Cross-Sectional Studies · Female · Humans · Male · Retrospective Studies
Substances
17-alpha-Hydroxyprogesterone
참고문헌
25편